CARE Ratings has made available the transcript of their Q4 FY26 earnings call, posted on their website following a discussion of their full-year 2026 financial performance during the May 14th meeting.

CARE Ratings saw a significant increase in Q4 EBITDA, growing by 28% Year-over-Year, reaching ₹607 million. The improvement in earnings margin is also noteworthy, rising to 46.5%.

CARE Ratings has released its Q4 earnings report, detailing the company's financial performance for the quarter. Investors and stakeholders can now review the financial highlights of the period.

CARE Ratings significantly boosted its Q4 profit by 47.2% compared to the previous quarter, reaching INR 52.8 crore, with an EPS of INR 17.5. The fiscal year 2026 income saw a 16.5% year-over-year increase, totaling INR 527.9 crore, and the stock currently trades at INR 1606.6.

CARE Ratings Ltd has decided to distribute a dividend of Rs. 14 per share for FY26, subject to approval at the Annual General Meeting. Additionally, they have reappointed B S R & Co. LLP as auditors for the next five years and granted ESOPs worth 55,000 to their employees.

CARE Ratings reported a significant 18% increase in consolidated revenue for their FY26, with standalone growth of 15%. The EBITDA margin surpassed 48% and 42% for standalone and consolidated figures respectively. Impressively, their standalone PAT margins reached 39%.

CARE Ratings has announced a final dividend of ₹14 per share, providing shareholders with an anticipated payout.

The Securities and Exchange Board of India (SEBI) has appointed Care Ratings as the Performance Rating for Research and Valuation Agencies (PaRRVA) to evaluate the past performance of investment advisors and analysts, ensuring a higher standard of service and credibility in the market.

CARE Ratings will convene on May 13, 2026, to review the FY26 results and decide on a potential final dividend. The trading window remains closed for 48 hours following the announcement due to SEBI insider trading regulations.

CARE Ratings announces a management change, with Dr. Nadir Bhalwani stepping down as Chief Investment Officer (CIO) by March 31, 2026. Starting April 1, 2026, CARE welcomes Dr. Shiju Rawther, who brings over two decades of technology expertise to his new role as CIO.